Related Experiment Video

Updated: May 27, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

The Two Faces of NF-κB Signaling in Cancer Development and Therapy

Ulf Klein1, Sankar Ghosh

  • 1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA. uk30@columbia.edu

Cancer Cell
|November 19, 2011
PubMed

Insights

Constitutive activation of nuclear factor-kappa B (NF-κB) signaling can drive cancer. However, new research shows NF-κB can also act as a tumor suppressor, increasing chemotherapy sensitivity when other oncogenes are present.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell signaling

Background:

  • Constitutive activation of nuclear factor-kappa B (NF-κB) signaling is frequently observed in various cancers, often promoting oncogenesis.
  • This has led to the development of anticancer strategies targeting NF-κB inhibition.

Discussion:

  • Recent studies reveal a dual role for NF-κB in cancer.
  • In specific contexts, particularly when prosurvival signals originate from other oncogenes, NF-κB activation enhances tumor cell sensitivity to cytotoxic chemotherapy.
  • This suggests NF-κB can function as a tumor suppressor under certain conditions.

Key Insights:

  • NF-κB signaling is not universally oncogenic.
  • The oncogenic or tumor-suppressive role of NF-κB depends on the cellular context and the presence of other signaling pathways.
  • Targeting NF-κB may require context-specific strategies.

Outlook:

  • Further investigation into the complex roles of NF-κB in different cancer types is warranted.
  • Understanding these nuances could lead to more effective and personalized cancer therapies.
  • Exploring combination therapies that modulate NF-κB activity alongside chemotherapy may improve treatment outcomes.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...